The conversation around these medications has evolved rapidly, from being prescribed solely for type 2 diabetes, to expanded use for the treatment of obesity, cardiovascular, kidney, and liver disease, as well as arthritis, sleep apnea and even for the treatment of substance abuse disorder
Waiting two or more years for an unapproved drug class is rarely the best option for someone who is losing weight and has medical reasons to stay on treatment
Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial
Alpha arbutin is famous for its ability to target melanin, the pigment responsible for skin color, in a gentle manner
A new class of medications for the treatment of type 2 diabetes mellitus (DM) called glucagon-like peptide 1 receptor agonists (GLP-1R) has been available since 2005